Opportunity Overview
American HealthCare Capital is pleased to exclusively introduce a patented, late-stage pre-commercial disposable infusion pump platform developed for use in ambulatory and home infusion therapy. The platform was designed as a potential next-generation alternative to traditional disposable infusion pumps, with the goal of improving delivery consistency, ease of use, safety profile, and manufacturing efficiency. It is manufacturer-ready, subject to final verification, validation, packaging, sterilization, and commercialization work.
Assets Included
The asset package includes the issued patent and related intellectual property, historical FDA 510(k) materials, production tooling, CAD/design files, technical and engineering documentation, bench testing materials, draft labeling and IFU materials, manufacturing knowledge, identified manufacturing relationships, and founder-supported technical transfer. Limited demonstration inventory and supporting market/commercial materials may also be included. The product has not been commercially launched.
Founder Investment and Ideal Buyer Profile
The owner has invested more than $1 million of founder capital into the development, tooling, regulatory preparation, and manufacturing readiness of the platform. Ownership is seeking a strategic acquirer with the capital, regulatory infrastructure, manufacturing capabilities, and commercial distribution channels required to complete final validation and bring the product to market.
Ideal buyers may include infusion device manufacturers, disposable medical device companies, home infusion suppliers, pharmaceutical delivery system companies, and strategic platforms seeking a next-generation ambulatory infusion asset.
Transaction Structure and Post Closing Transition
Valuation and transaction structure will be discussed with qualified buyers. The owner is willing to remain involved after a transaction to support technology transfer, final validation, manufacturing setup, and commercialization.